SCHEMBL23749475

SCHEMBL23749475

Cc1ccc(-n2c(=O)c(C(=O)Cl)cn(C(C)C)c2=O)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 12/20 0.38
▸ MET P08581 8/20 0.38
▸ KMT2A Q03164 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ HPD P32754 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ TLR9 Q9NR96 1/20 0.36
▸ NOTUM Q6P988 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MERTK Q12866 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23749506 0.89 AXL (0.40) AXLMETKMT2AALDH1A1SMN1; SMN2
SCHEMBL22511513 0.88 AXL (0.47) AXLMETMERTK
SCHEMBL19567654 0.87 NOTUM (0.47) AXLMETKMT2AALDH1A1SMN1; SMN2
SCHEMBL19567652 0.87 AXL (0.40) AXLMETSMN1; SMN2HPDLMNA
SCHEMBL30030688 0.86 KMT2A (0.39) AXLMETKMT2AALDH1A1SMN1; SMN2
SCHEMBL26608071 0.82 ALDH1A1 (0.50) AXLMETKMT2AALDH1A1SMN1; SMN2
SCHEMBL23749378 0.78 AXL (0.46) AXLMETALDH1A1HPDNOTUM
SCHEMBL21785475 0.78 NOTUM (0.47) AXLMETKMT2AALDH1A1SMN1; SMN2
SCHEMBL30030585 0.77 AXL (0.41) AXLMETKMT2AALDH1A1MAPT
SCHEMBL23749566 0.76 ALDH1A1 (0.41) AXLMETKMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12202835-B2 Substituted aromatic ring-linked dioxinoquinazolines and dioxinoquinolines as kinase inhibitors BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2025-01-21 — — US disclosed
CN-111196814-B Aromatic ring-linked dioxane quinazoline or quinoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2022-12-06 — — CN disclosed
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2022-01-06 — — US disclosed
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2022-01-06 — — US disclosed
EP-3865487-A1 AROMATIC RING-LINKED DIOXANE-QUINAZOLINE OR -QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2021-08-18 — — EP disclosed
EP-3865487-A1 AROMATIC RING-LINKED DIOXANE-QUINAZOLINE OR -QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2021-08-18 — — EP disclosed
CN-111196814-A Aromatic ring connecting dioxane quinazoline or quinoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2020-05-26 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF MERTK, AXL, TYRO3 AXL 2/4885MET 14/4885KMT2A 1804/4885
US-12202835-B2 Substituted aromatic ring-linked dioxinoquinazolines and dioxinoquinolines as kinase inhibitors MERTK, AXL, TYRO3 AXL 2/4885MET 12/4885KMT2A 1577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback